Inozyme Pharma Inc (INZY)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
1.1500 +0.0900 (+8.49%) 04/30/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 1.1600 +0.0100 (+0.87%) 18:05 ET
for Wed, Apr 30th, 2025
Results
download Want to compare other data? Select Fields| Symbol | INZY | XCUR | MAIA | ||
| Company | Inozyme Pharma Inc | Exicure Inc | Maia Biotechnology Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE Arca | ||
| Open | 1.0200 | 10.92 | 2.24 | ||
| High | 1.2000 | 11.25 | 2.47 | ||
| Low | 1.0046 | 10.04 | 2.15 | ||
| Last | 1.1500 | 10.45 | 2.34 | ||
| Change | +0.0900 | -0.47 | +0.04 | ||
| % Change | +8.49% | -4.30% | +1.74% | ||
| Volume | 822,900 | 11,300 | 370,400 | ||
| 20-Day Average Volume | 452,845 | 26,465 | 192,775 | ||
| Previous Close | 1.0600 | 10.92 | 2.30 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.9506 | 11.44 | 1.73 | ||
| 20-Day Raw Stochastic | 89.58% | 39.74% | 87.85% | ||
| 20-Day Relative Strength | 55.16% | 45.41% | 67.07% | ||
| Weighted Alpha | -67.05 | -68.72 | -29.01 | ||
| Today's Opinion | 56% Sell | 24% Sell | Hold | ||
| Previous Opinion | 56% Sell | 16% Buy | 24% Sell | ||
| Last Month's Opinion | 100% Sell | 88% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +17.28% since 04/23/25 | -7.19% since 04/23/25 | +14.15% since 04/23/25 | ||
| Low | 0.9326 on 04/28/25 | 10.04 on 04/30/25 | 1.80 on 04/28/25 | ||
| High | 1.2000 on 04/30/25 | 11.61 on 04/25/25 | 2.47 on 04/30/25 | ||
| 1-Month | |||||
| %Chg | +24.97% since 03/28/25 | -25.30% since 03/28/25 | +44.44% since 03/28/25 | ||
| Low | 0.7200 on 04/07/25 | 8.28 on 04/17/25 | 1.40 on 04/10/25 | ||
| High | 1.2000 on 04/30/25 | 14.11 on 04/01/25 | 2.47 on 04/30/25 | ||
| 3-Month | |||||
| %Chg | -21.23% since 01/30/25 | -3.33% since 01/30/25 | +25.81% since 01/30/25 | ||
| Low | 0.7200 on 04/07/25 | 7.18 on 02/25/25 | 1.40 on 04/10/25 | ||
| High | 1.6150 on 01/31/25 | 15.91 on 03/20/25 | 2.47 on 04/30/25 | ||
| 6-Month | |||||
| %Chg | -74.67% since 10/30/24 | +298.85% since 10/30/24 | -16.43% since 10/30/24 | ||
| Low | 0.7200 on 04/07/25 | 2.44 on 11/06/24 | 1.40 on 04/10/25 | ||
| High | 4.7417 on 11/04/24 | 36.00 on 11/27/24 | 3.48 on 11/07/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 68,094 | 68,990 | 68,050 | ||
| Shares Outstanding, K | 64,240 | 6,318 | 29,587 | ||
| Annual Sales | 0 | 500,000 | 0 | ||
| Annual Net Income | -102,020,000 | -9,700,000 | -23,250,000 | ||
| Last Quarter Sales | 0 | 0 | 0 | ||
| Last Quarter Net Income | -27,070,000 | -7,180,000 | -3,570,000 | ||
| 60-Month Beta | 1.39 | 3.74 | 0.38 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.42 on 03/10/25 | -3.39 on 03/18/25 | -0.17 on 03/21/25 | ||
| Latest Earnings Date | 05/06/25 | 06/16/25 | 05/13/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||